why choose us

First received: November 29, 2023

Clinical Trial: Terlipressin in Combined Hepatorenal Syndrome in Patients With Signs of Chronic Renal Disease

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Liver Cirrhosis

Study Type: OBSERVATIONAL


Official Title: Evaluation of the Natural History of Combined Hepatorenal Syndrome in Patients With Signs of Chronic Renal Disease

Brief Summary: The aim of this study is to evaluate the treatment response to terlipressin and albumin in patients with suspicion of HRS-AKI and signs of chronic parenchymal kidney disease (HRS-AKI-like syndrome) compared to patients without signs of chronic parenchymal kidney disease (HRS-AKI).

Read more